CSLLY News and Press, CSL Ltd ADR From 10/14/21

The New England Journal of Medicine Publishes First-of-its-Kind Study on Cell-Based Quadrivalent Seasonal Influenza Vaccine (QIVc) Efficacy in Children and Adolescents ≥2 to <18 Years of Age The New England Journal of Medicine Publishes First-of-its-Kind Study on Cell-...

Seqirus Awarded U.S. Government Contract to Develop Two Pandemic Influenza Vaccines - Seqirus will develop and evaluate two influenza A(H2Nx) virus vaccine candidates in support of U.S. government pandemic preparedness objectives - Company will utilize its combination of cel...

Seqirus Presents New Real-World Evidence Demonstrating Effectiveness of Cell-Based and Adjuvanted Seasonal Influenza Vaccines at IDWeek 2021 PR Newswire SUMMIT, N.J. , Sept. 29, 2021 /PRNewswire/ -- Seqirus, a global leader in influenza prevention and a busi...

Urban League of Philadelphia Names CSL's Elizabeth Walker to Board of Directors Global biotech leader CSL and the Urban League of Philadelphia are working to address some of the most pressing needs in the community, including efforts to strengthen Public Health, Leadership Devel...

The Project $1M portfolio had a good August, returning 4.7%, beating its target benchmark. A good August hasn't made for a strong year though, and the portfolio trails the S&P500 for 2021, though comfortably outperforms over the last 5 years. A complete exit from China-listed ...

CSL Plasma to Provide Flu Vaccines to U.S. Plasma Donors Vouchers enable donors at more than 290 U.S. CSL Plasma donation centers to access free flu shots at Walgreens pharmacy locations PR Newswire BOCA RATON, Fla. , Aug. 26, 2021 /PRNewswire/ -- CSL Pl...

Seqirus Announces Investment in Next-Generation Influenza Vaccine Technology, Self-Amplifying Messenger RNA (sa-mRNA) - Appoints Roberta Duncan as new program lead to drive technology advancement - Accelerates development of sa-mRNA vaccine candidates for seasonal and pandem...

The following slide deck was published by CSL Limited in conjunction with their 2021 Q4 earnings call. For further details see: CSL Limited 2021 Q4 - Results - Earnings Call Presentation

CSL Limited (CSLLY) Q4 2021 Earnings Conference Call August 17, 2021, 8:00 PM ET Company Participants Mark Dehring - Vice President, Investor Relations Paul Perreault - Chief Executive Officer Joy Linton - Chief Financial Officer Conference Call Participants Lyanne Harrison - Bank of America ...

July was a better month for the Project $1M portfolio, with the portfolio returning 2%, but still finishing down vs. S&P 500. Atlassian spared the portfolio a much worse finish and was the star for the month. Chinese regulatory risk reared its ugly head, significantly impactin...